Albemarle Introduces 2024 Financial Targets

Albemarle Corp. (ALB) outlined cost reduction initiative to deliver $100 million in annualized run-rate savings by 2021. It introduced 2024 financial targets.

"... We are confident in our ability to drive long-term value for stakeholders given our competitive advantages as we execute a clear strategy focused on growth and efficiency to generate significant cash." said Luke Kissam, Albemarle CEO.

For 2024, the company expects revenue to be in the range of $4.4 billion - $5.0 billion. It expects 5% annual dividend growth.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mallinckrodt plc announced Wednesday that the U.S. Food and Drug Administration or FDA has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated. Worldwide 5G mobile subscriptions are estimated to exceed 580 million by the end of 2021, according to the Ericsson Mobility Report. With subscriptions increasing at a rate of about a million per day, 5G remains on track to become the fastest adopted mobile generation in history. The growth in subscriptions is being lead by China, North America and the Gulf Cooperation Council markets. Elanco Animal Health Inc. (ELAN) and veterinary biopharmaceutical company Kindred Biosciences, Inc. (KIN) announced Wednesday they have entered into a definitive agreement for Elanco to acquire Kindred for $9.25 per share, or approximately $440 million. The acquisition further accelerates Elanco's...
Follow RTT